Sangamo Therapeutics (0R1D.L) Stock Price
$0.6 4.9%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Sangamo Therapeutics, AI stock picks, stock alerts and much more.
0R1D.L AI Stock Analysis
AI stock analysis for 0R1D.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Sangamo Therapeutics (0R1D.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Sangamo Therapeutics (0R1D.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Sangamo Therapeutics (0R1D.L), currently trading at $0.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0R1D.L
-
Sangamo Therapeutics, Inc.
-
Symbol
0R1D.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
181M
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$392.3 0.6% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$133.4 0.7% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.88 1% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.86 4.9% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$11.98 0.7% |
5 |
News
0R1D.L Alternative Data
Web Traffic
Sangamo Therapeutics receives an estimated 16998 monthly visitors to sangamo.com.
-
Web Traffic
16998
-
Change from Previous Month
16.2%
-
3 Month Change
2.1%
-
YoY Change
2.1%
Twitter Followers
Sangamo Therapeutics has 4,110 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.7% over the last month.
-
Twitter Followers
4110
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
1.5%
-
YoY Change
1.5%
Facebook Engagement
Sangamo Therapeutics has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
Sangamo Therapeutics currenly has an estimated 3 open job postings.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
200%
-
YoY Change
200%
Reddit Mentions
Sangamo Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
43,671 are following Sangamo Therapeutics on LinkedIn, up by 0.3% over the last month.
-
LinkedIn Followers
43671
-
Daily Change
0.3%
-
1 Month Change
0.3%
-
3 Month Change
1.3%
-
YoY Change
1.3%
LinkedIn Employees
According to LinkedIn, Sangamo Therapeutics has 267 employees, down by -1.1% over the last month.
-
LinkedIn Employees
267
-
Daily Change
1.1%
-
1 Month Change
1.1%
-
3 Month Change
3.6%
-
YoY Change
3.6%
Business Outlook
According to employee reviews, the business outlook among employees at Sangamo Therapeutics is 35 out of 100 (bearish).
-
Business Outlook
35
-
Change from Previous Month
0%
-
3 Month Change
7.9%
-
YoY Change
7.9%
News Mentions
Sangamo Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0R1D.L Financials
0R1D.L Key Metrics
-
Total Revenue
$6.4M
-
Net Income
-$30.6M
-
Earnings per Share
-$0.14
-
Free cash flow
-$26.1M
-
EBITDA
-$29.6M
-
EBITDA Ratio
-4.60277
-
Total Assets
$86.2M
0R1D.L 2-year Revenue & Income
0R1D.L 2-year Free Cash Flow
0R1D.L Technicals
0R1D.L SMA
0R1D.L RSI
FAQ
What's the current price of Sangamo Therapeutics (0R1D.L) Stock?
The price of an Sangamo Therapeutics (0R1D.L) share is $0.6.
What's the market cap of Sangamo Therapeutics?
The current market cap of Sangamo Therapeutics is 181M.
Should I buy or sell 0R1D.L?
Sangamo Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Sangamo Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Sangamo Therapeutics a good investment?
The current analysis of Sangamo Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Sangamo Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Sangamo Therapeutics (0R1D.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Sangamo Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Sangamo Therapeutics (0R1D.L) that investors often compare it to?
Sangamo Therapeutics (0R1D.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Sangamo Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Sangamo Therapeutics' stock price to be around $0.57 in 2026. Starting from the current price of $0.6, this represents a 5% change in price, indicating a bearish outlook for the stock.
How to buy Sangamo Therapeutics (0R1D.L) Stock?
Sangamo Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Sangamo Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.